Bioanalysis

Papers
(The H4-Index of Bioanalysis is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Flow Cytometry: Principles, Applications and Recent Advances65
Validation of Dried Blood Spot Sample Modifications to Two Commercially Available Covid-19 Igg Antibody Immunoassays50
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( Part 337
Dried Blood Spots in Doping Analysis27
Detection of Sars-Cov-2At the Point of Care26
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome ( Part 1 –R26
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV25
Green Bioanalytical Sample Preparation: Fabric Phase Sorptive Extraction24
Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development23
Assessment of Low Volume Sampling Technologies: Utility in Nonclinical and Clinical Studies22
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability &21
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback ( Part 2A –Recomm21
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective20
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Ma18
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides17
How the Covid-19 Pandemic is Changing Clinical Trial Conduct and Driving Innovation in Bioanalysis17
0.03760814666748